Press releases

Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla™ EGFR Biomarker Testing Among Patients with Lung Cancer

Biocartis Announces US FDA 510(k) submission of its Idylla™ MSI Test

Biocartis Launches Idylla™ GeneFusion Assay as Rapid Lab Workflow Solution for Gene Fusion Testing

New US Studies Demonstrate Idylla™ Allows Rapid First Assessment of Most Common EGFR Mutations Preceding NGS

Biocartis Announces Publication of Large Multi-Center Comparison Study with Idylla™ MSI Assay Showing Very Low Failure Rates and Excellent Concordance with Reference Methods

Biocartis Announces Ten Idylla™ Studies to be Published at Virtual AMP (US) Annual Meeting

Biocartis Announces CE-marking of its Fully Automated Idylla™ SARS-CoV-2 Test

Biocartis Announces Partnership with Endpoint Health to Develop Novel Companion Diagnostic in Critical Illness

Biocartis and GeneproDx To Collaborate on Fully Automated ThyroidPrint® test on Idylla™

Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™